Cargando…

Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration

PURPOSE: To estimate the risk of glaucoma or sustained ocular hypertension (OHT) related to anti-vascular endothelial growth factor (VEGF) injections for age-related macular degeneration (AMD). DESIGN: Retrospective chart review. SUBJECTS: Patients who received unilateral anti-VEGF injections for AM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wingard, Jeremy B, Delzell, Darcie AP, Houlihan, Nathan V, Lin, Jonathan, Gieser, Jon P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935302/ https://www.ncbi.nlm.nih.gov/pubmed/31920279 http://dx.doi.org/10.2147/OPTH.S232548

Ejemplares similares

Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration
por: Hanhart, Joel, et al.
Publicado: (2022)

Dietary Antioxidants in Age-Related Macular Degeneration and Glaucoma
por: Dziedziak, Jacek, et al.
Publicado: (2021)

Effect of Repeated Intravitreal Ranibizumab and Aflibercept Injections on the Cornea in Patients with Age-Related Macular Degeneration
por: Urban, Beata, et al.
Publicado: (2020)

Ocular Surface Temperature in Age-Related Macular Degeneration
por: Sodi, Andrea, et al.
Publicado: (2014)

Occupational radiation exposure and glaucoma and macular degeneration in the US radiologic technologists
por: Little, Mark P., et al.
Publicado: (2018)

CHANGES IN SYSTEMIC LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER INTRAVITREAL INJECTION OF AFLIBERCEPT OR BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
por: Angermann, Reinhard, et al.
Publicado: (2022)

Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy
por: Chen, Yu-Yen, et al.
Publicado: (2019)

The role of posterior vitreous detachment on the efficacy of anti-vascular endothelial growth factor intravitreal injection for treatment of neovascular age-related macular degeneration
por: Neudorfer, Meira, et al.
Publicado: (2018)

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
por: Bunker, Shannon, et al.
Publicado: (2015)

Macular Atrophy Development and Subretinal Drusenoid Deposits in Anti-Vascular Endothelial Growth Factor Treated Age-Related Macular Degeneration
por: Zarubina, Anna V., et al.
Publicado: (2017)

Measurement of the Inner Macular Layers for Monitoring of Glaucoma: Confounding Effects of Age-Related Macular Degeneration
por: Chew, Leila, et al.
Publicado: (2023)

Retinal ganglion cell function after repeated intravitreal injections of ranibizumab in patients with age-related macular degeneration
por: Nishimura, Tomoharu, et al.
Publicado: (2012)

Ganglion Cell Complex Evaluation in Exudative Age-Related Macular Degeneration after Repeated Intravitreal Injections of Ranibizumab
por: Perdicchi, Andrea, et al.
Publicado: (2015)

The effects of repeated Ozurdex injections on ocular hypertension
por: Bahadorani, Sepehr, et al.
Publicado: (2018)

Aqueous vascular endothelial growth factor and clinical outcomes correlation after single intravitreal injection of bevacizumab in patients with neovascular age-related macular degeneration
por: Cabral, Thiago, et al.
Publicado: (2017)

Reply: The role of posterior vitreous detachment on the efficacy of anti–vascular endothelial growth factor intravitreal injection for treatment of neovascular age-related macular degeneration
por: Neudorfer, Meira, et al.
Publicado: (2019)

Comment on: The role of posterior vitreous detachment on the efficacy of anti–vascular endothelial growth factor intravitreal injection for treatment of neovascular age-related macular degeneration
por: Awasthi, Upma, et al.
Publicado: (2019)

Baseline characteristics and progression of neovascular age-related macular degeneration in patients receiving over 60 intravitreal injections of anti-vascular endothelial growth factor
por: Prahs, Philipp, et al.
Publicado: (2023)

Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy
por: Nath, Madhu, et al.
Publicado: (2017)

The economic implications of the use of anti-vascular endothelial growth factor drugs in age-related macular degeneration
por: Azad, Rajvardhan, et al.
Publicado: (2007)

Anti-vascular endothelial growth factor in age-related macular degeneration: Puzzle or a silent beginning!
por: Natarajan, Sundaram
Publicado: (2013)

Vascular endothelial growth factor genetic polymorphisms and susceptibility to age-related macular degeneration in Tunisian population
por: Habibi, Imen, et al.
Publicado: (2014)

Vascular endothelial growth factor genetic polymorphisms and susceptibility to age-related macular degeneration in Tunisian population
por: Habibi, Imen, et al.
Publicado: (2012)

Vascular endothelial growth factor gene polymorphisms and association with age related macular degeneration in Indian patients
por: Gupta, Divya, et al.
Publicado: (2016)

Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration
por: Hussain, Rehan M, et al.
Publicado: (2021)

Intravitreal anti-vascular endothelial growth factor monotherapy in age-related macular degeneration with submacular hemorrhage
por: Maruyama-Inoue, Maiko, et al.
Publicado: (2023)

Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
por: Bhagat, Davis, et al.
Publicado: (2020)

Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline
por: Nikkhah, Homayoun, et al.
Publicado: (2018)

Early Macular Angiography among Patients with Glaucoma, Ocular Hypertension, and Normal Subjects
por: Chao, Shih-Chun, et al.
Publicado: (2019)

Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis
por: Souied, Eric H., et al.
Publicado: (2016)

Decrease in Ocular Blood Flow Thirty Minutes After Intravitreal Injections of Brolucizumab and Aflibercept for Neovascular Age-Related Macular Degeneration
por: Kato, Nobuhiro, et al.
Publicado: (2023)

Changes in the Ganglion Cell-inner Plexiform Layer after Consecutive Intravitreal Injections of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration Patients
por: Kim, Se Young, et al.
Publicado: (2020)

Effect of Repeated Intravitreal Injections in Glaucoma Spectrum Diseases
por: Vilares-Morgado, Rodrigo, et al.
Publicado: (2023)

Effect of Macular Vascular Density on Central Visual Function and Macular Structure in Glaucoma Patients
por: Jeon, Soo Ji, et al.
Publicado: (2018)

Concentration of Vascular Endothelial Growth Factor After Intracameral Bevacizumab Injection in Eyes With Neovascular Glaucoma
por: Lim, Tae Hoon, et al.
Publicado: (2009)

Incidence of Acute Endophthalmitis after Intravitreal Antivascular Endothelial Growth Factor Injection in Age-related Macular Degeneration
por: Seong, Hyo Jin, et al.
Publicado: (2022)

Potential Therapeutic Benefit of NAD(+) Supplementation for Glaucoma and Age-Related Macular Degeneration
por: Cimaglia, Gloria, et al.
Publicado: (2020)

Changes in Scleral Thickness Following Repeated Anti-vascular Endothelial Growth Factor Injections
por: Wang, Yao, et al.
Publicado: (2022)

Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration
por: Kim, Ramasamy
Publicado: (2007)

Association between Vascular Endothelial Growth Factor Polymorphisms and Age-Related Macular Degeneration: An Updated Meta-Analysis
por: Barchitta, Martina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1rvafrcv4ss1nijcp72mqs61at